Boston

Health Tech

Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice

By Casey Ross

Health

How the psychology of a $4.99 price tag might influence who undergoes heart surgery

By Eric Boodman

Frank Reynolds, CEO of PixarBio, sentenced to 7 years for defrauding investors

Biotech

Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison

By Jonathan Saltzman — Boston Globe

Biotech

Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows

By Kate Sheridan

Health

Watch: Hollywood motion capture technology finds a new role in hospital rehab

By Alex Hogan

Biotech

Two more failed Alzheimer’s drugs sharpen focus on Biogen’s chances for aducanumab

By Damian Garde

Health Tech

For homebound people and their distant caregivers, smarter speakers to keep track of their health

By Hiawatha Bray — Boston Globe

Health

‘We need everyone for this’: U.S. hospitals harnessing resources to brace for any spike in coronavirus cases

By Megan Thielking

Biotech

Beam Therapeutics raises $180 million in IPO

By Jonathan Saltzman — Boston Globe

Biotech

Biogen wins patent challenge to key multiple sclerosis drug

By Adam Feuerstein

Adam's Take

If biotech had a Mount Rushmore, whose heads would you chisel in the granite?

By Adam Feuerstein

Biotech

European regulators could take a harder line on the review of an Agios blood cancer drug

By Adam Feuerstein

Health Tech

‘It’s very easy to get starry-eyed about AI’: Experts offer warnings on digital disruption in health care

By Elizabeth Cooney

Adam's Take

As Biogen gets squishy on timing for an aducanumab filing, the clock is ticking

By Adam Feuerstein

Health Tech

In coronavirus response, AI is becoming a useful tool in a global outbreak, data experts say

By Casey Ross

Biotech

In a pivot, Decibel Therapeutics loses its founding CEO — and some of its discovery programs

By Kate Sheridan

Biotech

Three star scientists announce plan to solve biotech’s ‘missing women’ problem

By Sharon Begley

Politics

Top Harvard chemist charged with lying about ties to Chinese government program

By Rebecca Robbins

Biotech

Acceleron pulmonary hypertension drug succeeds in mid-stage clinical trial

By Adam Feuerstein

Biotech

The suburbs are cheaper, but they don’t have what Kendall Square has for biotechs: serendipity

By Scott Kirsner — Boston Globe

Biotech

‘The gurus of sperm’: Ohana Biosciences is taking a different approach to fertility

By Kate Sheridan

In the Lab

DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations

By Sharon Begley

Biotech

How fast can biotech come up with a vaccine for the latest outbreak?

By Damian Garde

Pharma

Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme

By Jonathan Saltzman — Boston Globe

Business

Former Insys executive who dressed as giant fentanyl bottle gets 26-month sentence

By Jonathan Saltzman — Boston Globe

College student with disease that causes premature aging is heartened by medical advances

Alkermes sued over death of man who overdosed after taking addiction treatment Vivitrol

New partnership tries to make up for missing drug data in cost-effectiveness analyses

In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs

Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice

How the psychology of a $4.99 price tag might influence who undergoes heart surgery

Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison

Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows

Watch: Hollywood motion capture technology finds a new role in hospital rehab

Two more failed Alzheimer’s drugs sharpen focus on Biogen’s chances for aducanumab

For homebound people and their distant caregivers, smarter speakers to keep track of their health

‘We need everyone for this’: U.S. hospitals harnessing resources to brace for any spike in coronavirus cases

Beam Therapeutics raises $180 million in IPO

Biogen wins patent challenge to key multiple sclerosis drug

If biotech had a Mount Rushmore, whose heads would you chisel in the granite?

European regulators could take a harder line on the review of an Agios blood cancer drug

‘It’s very easy to get starry-eyed about AI’: Experts offer warnings on digital disruption in health care

As Biogen gets squishy on timing for an aducanumab filing, the clock is ticking

In coronavirus response, AI is becoming a useful tool in a global outbreak, data experts say

In a pivot, Decibel Therapeutics loses its founding CEO — and some of its discovery programs

Three star scientists announce plan to solve biotech’s ‘missing women’ problem

Top Harvard chemist charged with lying about ties to Chinese government program

Acceleron pulmonary hypertension drug succeeds in mid-stage clinical trial

The suburbs are cheaper, but they don’t have what Kendall Square has for biotechs: serendipity

‘The gurus of sperm’: Ohana Biosciences is taking a different approach to fertility

DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations

How fast can biotech come up with a vaccine for the latest outbreak?

Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme

Former Insys executive who dressed as giant fentanyl bottle gets 26-month sentence